Exagen Inc expected to post a loss of 44 cents a share - Earnings Preview

Exagen

23/07/2021 13:37

* Exagen Inc  XGN.OQ   XGN.O  is expected to show a rise in
quarterly revenue when it reports results on July 26
(estimated). 
* The Vista, California-based company is expected to report   a
28.3% increase in revenue to $11.483 million from $8.95 million
a year ago, according to the mean estimate from 6 analysts,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Exagen Inc is for a
loss of 44 cents per share. For the same quarter last year, the
company reported a loss of 27 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Exagen Inc is
$25​, about 47% above​ its last closing price of $13.26. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.47       -0.47      -0.48     Missed  -2.3
 Dec. 31 2020  -0.38       -0.41      -0.27     Beat    33.4
 Sep. 30 2020  -0.47       -0.47      -0.34     Beat    28.4​
 Jun. 30 2020  -0.75       -0.76      -0.27     Beat    64.4
 Mar.          -0.48​      -0.49      -0.44     Beat    10.2​
 31​ 2020​                                              
 Dec. 31 2019  -0.33       -0.37      -0.27     Beat    26.4​
 Sep. 30 2019  -2.40       -2.40      -2.30     Beat    4.1
 This summary was machine generated July 23 at 12:37 GMT.  All
figures in US dollars unless otherwise stated